RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Operating Expenses Summary of RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.'s latest annual operating expenses in 2023 was 2.08 Million USD , up 11.25% from previous year.
RetinalGenix Technologies Inc.'s latest quarterly operating expenses in 2024 Q2 was 662.64 Thousand USD , down -69.1% from previous quarter.
RetinalGenix Technologies Inc. reported a annual operating expenses of 1.87 Million USD in annual operating expenses 2022, up 25.37% from previous year.
RetinalGenix Technologies Inc. reported a annual operating expenses of 1.49 Million USD in annual operating expenses 2021, down -9.11% from previous year.
RetinalGenix Technologies Inc. reported a quarterly operating expenses of 662.64 Thousand USD for 2024 Q2, down -69.1% from previous quarter.
RetinalGenix Technologies Inc. reported a quarterly operating expenses of 2.08 Million USD for 2023 FY, up 11.25% from previous quarter.

Annual Operating Expenses Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Operating Expenses of RetinalGenix Technologies Inc. (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	2.08 Million USD	11.25%
2022	1.87 Million USD	25.37%
2021	1.49 Million USD	-9.11%
2020	1.64 Million USD	104.32%
2019	805.81 Thousand USD	54942.01%
2018	1464.00 USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	2.14 Million USD	296.72%
2024 Q2	662.64 Thousand USD	-69.1%
2023 FY	2.08 Million USD	11.25%
2023 Q4	540.65 Thousand USD	-21.13%
2023 Q2	351.18 Thousand USD	-31.1%
2023 Q1	509.68 Thousand USD	-56.27%
2023 Q3	685.5 Thousand USD	95.2%
2022 Q1	216.24 Thousand USD	-47.04%
2022 Q4	1.16 Million USD	328.73%
2022 Q3	271.83 Thousand USD	22.21%
2022 FY	1.87 Million USD	25.37%
2022 Q2	222.43 Thousand USD	2.86%
2021 Q1	683.68 Thousand USD	69.3%
2021 FY	1.49 Million USD	-9.11%
2021 Q4	408.29 Thousand USD	-25.74%
2021 Q3	549.84 Thousand USD	-19.58%
2021 Q2	683.68 Thousand USD	0.0%
2020 Q2	466.83 Thousand USD	0.0%
2020 Q4	403.83 Thousand USD	-13.75%
2020 FY	1.64 Million USD	104.32%
2020 Q3	468.2 Thousand USD	0.29%
2020 Q1	466.83 Thousand USD	0.0%
2019 FY	805.81 Thousand USD	54942.01%
2018 FY	1464.00 USD	0.0%

Peer Operating Expenses Comparison of RetinalGenix Technologies Inc.

Name	Operating Expenses	Operating Expenses Difference
Cell MedX Corp.	313.43 Thousand USD	-565.874%